Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Codanin-1 (CDAN1)** is an essential and ubiquitously expressed protein involved in the maintenance of nuclear structure, chromatin assembly, and the cell cycle[3][4]. It interacts with histone chaperones ASF1A and ASF1B and is implicated in chromatin condensation by sequestering histone chaperones, thereby impacting nucleosome formation and downstream gene expression[1][2]. Mutations in CDAN1 cause congenital dyserythropoietic anemia type I, leading to defective red blood cell production[3]. While it has a central role in basic cell biology and erythropoiesis, it is not an established therapeutic target, and no drug interactions or established biomarker roles have been reported[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Codanin-1 (CDAN1).